PHILADELPHIA, Aug. 26, 2008 (GLOBE NEWSWIRE) (PRIME NEWSWIRE) -- Eurand N.V. (Nasdaq:EURX), a specialty pharmaceutical company that develops enhanced pharmaceutical and biopharmaceutical products based on its proprietary drug formulation technologies, announced today that it is scheduled to present at the upcoming Thomas Weisel Partners Healthcare Conference 2008 in Boston, Mass., on Thursday, September 4, 2008. Gearoid Faherty, Chief Executive Officer of Eurand, will be presenting.
